GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Suisse Corp (OTCPK:CSUI) » Definitions » EPS without NRI

CSUI (Cannabis Suisse) EPS without NRI : $-0.03 (TTM As of Aug. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cannabis Suisse EPS without NRI?

Cannabis Suisse's earnings per share without non-recurring items for the three months ended in Aug. 2024 was $-0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Aug. 2024 was $-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Cannabis Suisse's EPS without NRI or its related term are showing as below:

CSUI's 3-Year EPS without NRI Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 8.7
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Cannabis Suisse's EPS (Diluted) for the three months ended in Aug. 2024 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 was $-0.04.

Cannabis Suisse's EPS (Basic) for the three months ended in Aug. 2024 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2024 was $-0.04.


Cannabis Suisse EPS without NRI Historical Data

The historical data trend for Cannabis Suisse's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Suisse EPS without NRI Chart

Cannabis Suisse Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only -0.01 -0.01 -0.01 -0.01 0.01

Cannabis Suisse Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.03 -

Competitive Comparison of Cannabis Suisse's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Suisse's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Suisse's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Suisse's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Cannabis Suisse's PE Ratio without NRI falls into.



Cannabis Suisse EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Suisse  (OTCPK:CSUI) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cannabis Suisse EPS without NRI Related Terms

Thank you for viewing the detailed overview of Cannabis Suisse's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Suisse Business Description

Traded in Other Exchanges
N/A
Address
10 North Neuman Street, Suite A, Jacksonville, FL, USA, 32202
Cannabis Suisse Corp is engaged in the rental of commercial office and industrial space.
Executives
Scott Walker Mcalister director, 10 percent owner, officer: CEO/CFO 10 NORTH NEWNAN STREET, SUITE A, JACKSONVILLE FL 32202